Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
DTCFF Stock — Defence Therapeutics Inc
Defence Therapeutics Inc (DTCFF)
Updated October 16, 2026.
DTCFF is a Stock. Total return is -90.1% over the past 5.4 years, 189.5 points behind SPY at 99.4%.
Defence Therapeutics Inc. is a Canadian biopharmaceutical company developing a platform technology called Accum that enhances the efficacy and safety of biological drugs, with a pipeline focused on antibody drug conjugates for cancer treatment, cell-based cancer vaccines, and mRNA and protein-based vaccines for cancer and infectious diseases. The company does not currently have an established distribution schedule. This stock may appeal to investors seeking exposure to early-stage biotechnology development with no current income component.
DTCFF performance versus SPY
Price and return data through 2026-10-16.
Total return is -90.1% over the past 5.4 years, 189.5 points behind SPY at 99.4%. Over the past year its total return — price change plus distributions reinvested — is -53.5%. Its deepest 1-year drawdown was 63.2%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -31.9% | — |
| 3M | -21.1% | — |
| 6M | -33.0% | — |
| YTD | -55.5% | — |
| 1Y | -53.5% | — |
| 2Y CAGR | — | -22.20% |
| 3Y CAGR | — | -49.20% |
| 5Y CAGR | — | -45.50% |
| Since inception (5.4 years) | -90.1% | -34.70% |
DTCFF key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 05/18/2021
- Distribution frequency
- None
- Last close
- $0.25 (as of 2026-10-16)
- Market cap
- $18,787,883
- Average volume
- 90650.0
- Beta
- 1.51
- Payout ratio
- 0.0%
- EPS
- $-0.08
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
DTCFF risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 63.2%.
Who may consider DTCFF — and who may not
It is a weaker fit for investors who need monthly cash flow (DTCFF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on DTCFF
Frequently asked questions
Does DTCFF pay monthly?
No. DTCFF does not currently distribute.
When does DTCFF pay a dividend?
DTCFF does not currently distribute.
How has DTCFF performed?
Total return is -90.1% over the past 5.4 years, 189.5 points behind SPY at 99.4%. Over the past year its total return — price change plus distributions reinvested — is -53.5%. Its deepest 1-year drawdown was 63.2%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.